YARTEMLEA Trademark
Trademark Overview
On Friday, September 8, 2023, a trademark application was filed for YARTEMLEA with the United States Patent and Trademark Office. The USPTO has given the YARTEMLEA trademark a serial number of 98171267. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 6, 2024. This trademark is owned by Omeros Corporation. The YARTEMLEA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods
General Information
| Serial Number | 98171267 |
| Word Mark | YARTEMLEA |
| Filing Date | Friday, September 8, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 11, 2024 |
Trademark Statements
| Description of Mark | The mark consists of YARTEMLEA" in all capital letters. Three horizontally stacked waving lines, the top two of which are three times longer than the lowest line, are positioned above the last three letters of "YARTEMLEA" with the top two lines extending to the right of the word. All the letters in the word "YARTEMLEA" and the two top waving lines are purple and the lowest waving line is gold. |
| Goods and Services | Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods |
| Indication of Colors claimed | The color(s) purple and gold is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, October 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Omeros Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98119 |
| Party Name | Omeros Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98119 |
Trademark Events
| Event Date | Event Description |
| Tuesday, September 12, 2023 | NEW APPLICATION ENTERED |
| Sunday, October 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 3, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, May 3, 2024 | ASSIGNED TO EXAMINER |
| Monday, May 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 22, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 11, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 11, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 14, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 14, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, November 14, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 14, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, November 14, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, November 14, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
